Bio-One acquisition
This article was originally published in The Tan Sheet
Executive Summary
Orlando, Fla.-based supplement firm purchases fifth majority stake in a Chinese herbal company in recent months with acquisition of 51% share of a firm in the Henan Province; the acquisition is expected to close in 90 days. The Chinese firm, which reported $17 mil. in 2003 revenues, will retain its present management team. The deal continues Bio-One's vertical integration and international expansion strategy following the April purchase of Canadian distributor and manufacturer INI (1"The Tan Sheet" April 12, 2004, p. 12)...
You may also be interested in...
Bio-One Supplement Firm Buys Interactive Nutrition International
Bio-One continues its aggressive acquisition strategy with its purchase of Canadian manufacturer and distributor Interactive Nutrition International, the firm announced April 1
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.